Back to news archive
News 2018-03-25

EPO Grants Gradientech’s Patent on AST

Gradientech today received the certificate from EPO, the European Patent Office, certifying that a European patent with patent no. 3019625 has been granted in respect of the invention described in the patent specification.

The patent covers the proprietary minimum inhibitory concentration (MIC) determination of a bacteria sample within a microfluidic controlled environment. This invention is an important part of the technology platform of the Company’s diagnostic system QuickMIC™ for ultra-rapid AST in development.

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2024 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book